These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 8642506

  • 1. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 2. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T, Ishikita T, Matsuura H, Saji T.
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [Abstract] [Full Text] [Related]

  • 3. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F, Uese K, Hashimoto I, Hamamichi Y, Tsubata S, Fukahara K, Murakami A, Miyawaki T.
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [Abstract] [Full Text] [Related]

  • 4. [Systemic lupus erythematosus with pulmonary hypertension--normalization of pulmonary artery pressure by long-term administration of beraprost sodium].
    Ubukata M, Motegi M, Sendo Y, Suzuki T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1307-12. PubMed ID: 8583727
    [Abstract] [Full Text] [Related]

  • 5. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
    Andreassen AK, Madsen S, Kjekshus J, Simonsen S.
    Tidsskr Nor Laegeforen; 2001 Apr 20; 121(10):1220-3. PubMed ID: 11402748
    [Abstract] [Full Text] [Related]

  • 6. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV, Genthner DE, Panella MM, Rich S.
    N Engl J Med; 1998 Jan 29; 338(5):273-7. PubMed ID: 9445406
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
    Tamura M, Kurumatani H, Matsushita T.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Mar 29; 64(3):197-202. PubMed ID: 11334556
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C, Escribano Subias P, Tello de Meneses R, Delgado Jiménez JF, Sadia Pérez D, Velázquez Martín MT, Gómez Sánchez MA, Sáenz de la Calzada C.
    Rev Esp Cardiol; 2004 Oct 29; 57(10):946-51. PubMed ID: 15469792
    [Abstract] [Full Text] [Related]

  • 9. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O.
    J Heart Lung Transplant; 2007 Apr 29; 26(4):357-62. PubMed ID: 17403477
    [Abstract] [Full Text] [Related]

  • 10. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.
    Saji T, Ozawa Y, Ishikita T, Matsuura H, Matsuo N.
    Am J Cardiol; 1996 Jul 15; 78(2):244-7. PubMed ID: 8712155
    [Abstract] [Full Text] [Related]

  • 11. Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.
    Ichida F, Uese K, Hamamichi Y, Hashimoto I, Tsubata S, Fukahara K, Murakami A, Miyawaki T.
    Acta Paediatr Jpn; 1998 Feb 15; 40(1):14-9. PubMed ID: 9583194
    [Abstract] [Full Text] [Related]

  • 12. Sildenafil for primary and secondary pulmonary hypertension.
    Watanabe H, Ohashi K, Takeuchi K, Yamashita K, Yokoyama T, Tran QK, Satoh H, Terada H, Ohashi H, Hayashi H.
    Clin Pharmacol Ther; 2002 May 15; 71(5):398-402. PubMed ID: 12011826
    [Abstract] [Full Text] [Related]

  • 13. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
    Saji T, Nakayama T, Ishikita T, Matsuura H.
    Nihon Rinsho; 2001 Jun 15; 59(6):1132-8. PubMed ID: 11411125
    [Abstract] [Full Text] [Related]

  • 14. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N, McAlpine L, Peacock AJ, Madhok R.
    Arthritis Rheum; 1998 Mar 15; 41(3):466-9. PubMed ID: 9506575
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.
    Circulation; 2003 Oct 28; 108(17):2066-9. PubMed ID: 14568893
    [Abstract] [Full Text] [Related]

  • 16. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
    Schranz D, Zepp F, Iversen S, Wippermann C, Huth R, Zimmer B, Jüngst BK, Oelert H.
    Crit Care Med; 1992 Sep 28; 20(9):1243-9. PubMed ID: 1521438
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease.
    Durongpisitkul K, Jakrapanichakul D, Laohaprasitiporn D, Soongswang J, Chanthong P, Nana A.
    J Med Assoc Thai; 2005 Nov 28; 88 Suppl 8():S60-5. PubMed ID: 16856428
    [Abstract] [Full Text] [Related]

  • 18. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
    Stricker H, Domenighetti G, Fiori G, Mombelli G.
    Schweiz Med Wochenschr; 1999 Jun 19; 129(24):923-7. PubMed ID: 10413827
    [Abstract] [Full Text] [Related]

  • 19. [Acute and long-term effects of captopril in resistance-induced pulmonary hypertension in childhood and adolescence].
    Müller-Deile K, Rupprath G, Vogt J.
    Monatsschr Kinderheilkd; 1986 Dec 19; 134(12):854-7. PubMed ID: 3102952
    [Abstract] [Full Text] [Related]

  • 20. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ.
    J Am Coll Cardiol; 2004 Jun 16; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.